Buy, Sell or Hold: Trulieve Cannabis (TRUL-CN)

Home

Daily Stock Opinions and Ratings

Trulieve Cannabis (TRUL-CN)

CNSX:TRUL

5.60

0.19 (3.28%) 1d

Nervous markets await Nvidia

BUY

It's a vertically integrated medical marijuana company that is dominant in Florida with a growing presence in the US northeast. They grow, process and sell at their own stores. They just opened their 73rd this week. They've been turning a profit since 2017 and keep posting good numbers. Too bad it trades only in Canada.

Showing 1 to 1 of 1 entries

Trulieve Cannabis(TRUL-CN) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Trulieve Cannabis is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Trulieve Cannabis(TRUL-CN) Frequently Asked Questions

What is Trulieve Cannabis stock symbol?

Trulieve Cannabis is a Canadian stock, trading under the symbol TRUL-CN on the Canadian Securities Exchange (). It is usually referred to as or TRUL-CN

Is Trulieve Cannabis a buy or a sell?

In the last year, there was no coverage of Trulieve Cannabis published on Stockchase.

Is Trulieve Cannabis a good investment or a top pick?

Trulieve Cannabis was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Trulieve Cannabis.

Why is Trulieve Cannabis stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Trulieve Cannabis worth watching?

0 stock analysts on Stockchase covered Trulieve Cannabis In the last year. It is a trending stock that is worth watching.

What is Trulieve Cannabis stock price?

On 2025-05-27, Trulieve Cannabis (TRUL-CN) stock closed at a price of $5.6.

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Martin Cobb, ASIP

Lorne Steinberg Wealth Management

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Derek Warren

Lincluden Investment Mgmnt

Stockchase Insights

5i Research

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.